Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysis.

Shadman M, Brown JR, Mohseninejad L, Yang K, Burnett H, Neupane B, Williams R, Lamanna N, O'Brien SM, Tedeschi A, Tam CS

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice.

Blombery P, Chatzikonstantinou T, Gerousi M, Rosenquist R, Gaidano G, Pospisilova S, Roberts AW, Birkinshaw RW, Rossi D, Scarfo L, Seymour JF, Stilgenbauer S, Wiestner A, Woyach JA, Brown JR, Ghia P, Stamatopoulos K, ERIC, the European Research Initiative on CLL

Mutations and translocations associated with venetoclax resistance in chronic lymphocytic leukemia.

Mashima K, Kuang Y, Fernandes SM, Xu S, Hanna B, Shupe S, Mikhaleva M, Santos RA, Predko P, Fardoun R, Bidgoli A, Martindale SP, Naeem A, Davids MS, Paweletz C, Brown JR

Ethnicity Risk and Exertional Rhabdomyolysis: A Narrative Review.

Nguyen A, Thomassen A, MacDonald EM, Rodriguez VA, Brown JM, Shekoohi S, Kaye AD

First-in-Human Percutaneous Transseptal Retrieval of Embolized Transcatheter Valve in the Left Ventricle: The RETRIEVE Trial.

Giustino G, Koulogiannis K, Blitz L, van Boxtel B, Cohen B, Villablanca P, Gillam L, Brown J 3rd, Kipperman R, Genereux P

Metabolic dysfunction over a life course key to healthy ageing inequality.

Littlewood K, Gegic J, Hickman M, Henson RCJ, Bishop JR, Kershaw T, Diamond P, Slabaugh G, Tranos E, Vasilaki A, Tennant D, Courtin E, Chan LF, Henson SM, CELLO Network

Validation of the Ligamentous-Fossa-Foveolar Complex (LFFC) Grading System With Clinical Correlation for Patients Undergoing Hip Arthroscopy.

Kuhns BD, Chang PS, Brown J, Stezelberger VM, Ruzbarsky JJ, Godin J, Vidal L, Philippon MJ

Rapid post-release adaptation of released orphan elephants from a rescue centre to a national park in Sri Lanka based on faecal glucocorticoid metabolite analyses.

Perera BV, Silva-Fletcher A, Thitaram C, Kosaruk W, Brown JL

Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in Diabetes Prevention Program (DPP) Outcomes Study (DPPOS).

Tjaden AH, Braffett BH, Butera NM, Araneta MR, Carmichael O, Groessl EJ, Hazuda HP, Hoskin MA, Ibebuogu U, Magee MF, Mau M, Stich T, Soliman D, Wallia A, Temprosa M, Golden SH, Diabetes Prevention Program Research Group

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.

Sasi BK, Tarantelli C, Martindale S, Civanelli E, Cannas E, Sartori G, Arribas AJ, Fernandes SM, Shupe SJ, Machado JH, Tyekucheva S, Ren Y, Lahn M, Van der Veen L, Di Conza G, Bertoni F, Brown JR